Buy Ovagen Peptide (20mg)
Ovagen Peptide Description
This research-grade Ovagen lyophilized peptide complex provides laboratories with high-purity bioregulator material for liver and gastrointestinal tract investigations. The Khavinson developed tripeptide demonstrates specific affinity for hepatic tissue research applications.
Each peptide vial delivers consistent results through rigorous quality control and independent testing protocols. Manufactured in USA facilities using the highest standards, this peptide bioregulator supports liver function studies and cellular research.
Third-party verified purity ensures reliable experimental outcomes for qualified research institutions. Strictly for in vitro research applications only.
Peptide Information
| Property | Value |
|---|---|
| Peptide Sequence | H-Glu-Asp-Leu-OH |
| Molecular Formula | C₁₅H₂₅N₃O₈ |
| Molecular Weight | 375.37 g/mol |
| PubChem CID | 444128 |
Ovagen Research
HIV-1 Protease Inhibition Research
The most substantive research on the Glu-Asp-Leu tripeptide comes from HIV-1 protease inhibition studies where EDL functions as a competitive inhibitor derived from the viral transframe region (TFR). The tripeptide represents one of the smallest and most potent analogues derived from the transframe octapeptide (TFP) Phe-Leu-Arg-Glu-Asp-Leu-Ala-Phe, which naturally occurs at the N-terminus of the HIV-1 transframe region[1].
Kinetic analysis demonstrates that Glu-Asp-Leu exhibits competitive inhibition of mature HIV-1 protease with a Ki value of approximately 50 μM. This inhibitory potency is remarkable considering the tripeptide’s simple structure compared to conventional HIV protease inhibitors. The closely related tripeptide Glu-Asp-Phe shows even greater potency with a Ki value of approximately 20 μM[1].
References
- J. M. Louis, F. Dyda, N. T. Nashed, A. R. Kimmel, and D. R. Davies, “Hydrophilic Peptides Derived from the Transframe Region of Gag-Pol Inhibit the HIV-1 Protease,” American Chemical Society (ACS), Feb. 1998. doi: 10.1021/bi972059x. https://doi.org/10.1021/bi972059x
Endotoxin Ovagen

Ovagen (251522)

Ovagen (251522E)
×
Disclaimer: For Research Purposes Only
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides. . .




